International nonproprietary name: Bovhyaluronidase azoximer*.

Original antifibrotic product for combined therapy of connective tissue hyperplasia diseases (adhesions, cicatricial and fibrotic processes).

Therapeutic areas: gynecology, urology, dermatology and venereology, pulmonology and phthisiology, surgery, esthetic medicine, and rheumatology.

Dosage forms: suppositories, and lyophilizate for preparation of solution for injection.

*The World Health Organization (WHO) assigned an international nonproprietary name (INN) to the Russian product Longidaza® in 2015.
© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.